These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 11543798)

  • 1. Liposomal amphotericin B (Ambisome) is safe and effective in the treatment of invasive mycosis in organ transplant patients.
    Merhav H; Nakache R; Houri I; Orni-Wasserlauf R
    Transplant Proc; 2001 Sep; 33(6):2937-8. PubMed ID: 11543798
    [No Abstract]   [Full Text] [Related]  

  • 2. Ten years' experience with liposomal amphotericin B in transplant recipients at Huddinge University Hospital.
    Ringdén O
    J Antimicrob Chemother; 2002 Feb; 49 Suppl 1():51-5. PubMed ID: 11801582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AmBisome today: expanding the perspectives on liposomal amphotericin B.
    Richardson M
    Acta Biomed; 2006; 77 Suppl 2():3-4. PubMed ID: 16918058
    [No Abstract]   [Full Text] [Related]  

  • 4. A retrospective clinical comparison between antifungal treatment with liposomal amphotericin B (AmBisome) and conventional amphotericin B in transplant recipients.
    Tollemar J; Andersson S; Ringdén O; Tydén G
    Mycoses; 1992; 35(9-10):215-20. PubMed ID: 1291871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liposomal amphotericin B treatment for neonatal fungal infections.
    Scarcella A; Pasquariello MB; Giugliano B; Vendemmia M; de Lucia A
    Pediatr Infect Dis J; 1998 Feb; 17(2):146-8. PubMed ID: 9493812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is liposomal amphotericin B (ambisome) an effective prophylaxis of mycotic infections after liver transplantation?
    Braun F; Rüchel R; Lorf T; Canelo R; Müller A; Sattler B; Ringe B
    Transplant Proc; 1998 Jun; 30(4):1481-3. PubMed ID: 9636602
    [No Abstract]   [Full Text] [Related]  

  • 7. Liposomal amphotericin B found safe and effective.
    AIDS Patient Care STDS; 1998 Jan; 12(1):69. PubMed ID: 11361899
    [No Abstract]   [Full Text] [Related]  

  • 8. Fungal infection and liposomal amphotericin B (AmBisome) therapy in liver transplantation: a 2 year review.
    Fisher NC; Singhal S; Miller SJ; Hastings JG; Mutimer DJ
    J Antimicrob Chemother; 1999 Apr; 43(4):597-600. PubMed ID: 10350395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liposomal amphotericin B compared with amphotericin B deoxycholate in the treatment of documented and suspected neutropenia-associated invasive fungal infections.
    Leenders AC; Daenen S; Jansen RL; Hop WC; Lowenberg B; Wijermans PW; Cornelissen J; Herbrecht R; van der Lelie H; Hoogsteden HC; Verbrugh HA; de Marie S
    Br J Haematol; 1998 Oct; 103(1):205-12. PubMed ID: 9792309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liposomal amphotericin B for the treatment of severe fungal infection.
    Michaud D
    Dynamics; 2001; 12(1):17-21. PubMed ID: 11982230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disseminated Penicillium marneffei infection in a renal-transplant recipient successfully treated with liposomal amphotericin B.
    Wang JL; Hung CC; Chang SC; Chueh SC; La MK
    Transplantation; 2003 Oct; 76(7):1136-7. PubMed ID: 14557769
    [No Abstract]   [Full Text] [Related]  

  • 12. Experience with liposomal Amphotericin-B in 60 patients undergoing high-dose therapy and bone marrow or peripheral blood stem cell transplantation.
    Krüger W; Stockschläder M; Rüssmann B; Berger C; Hoffknecht M; Sobottka I; Kohlschütter B; Kroschke G; Kröger N; Horstmann M
    Br J Haematol; 1995 Nov; 91(3):684-90. PubMed ID: 8555076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of liposomal amphotericin B in bone marrow transplant.
    Sastry PS; Parikh PM; Kulkarni PS; Bhagwat R; Gadade H
    J Postgrad Med; 2005; 51 Suppl 1():S49-52. PubMed ID: 16519256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prophylaxis and therapy using liposomal amphotericin B (AmBisome) for invasive fungal infections in children undergoing organ or allogeneic bone-marrow transplantation.
    Ringdén O; Andström EE; Remberger M; Dahllöf G; Svahn BM; Tollemar J
    Pediatr Transplant; 1997 Nov; 1(2):124-9. PubMed ID: 10084772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Compassionate use protocol initiated for AmBisome.
    J Int Assoc Physicians AIDS Care; 1996 Apr; 2(4):60. PubMed ID: 11363524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AmBisome: adds to the body of knowledge and familiarity of use.
    Richardson M
    Acta Biomed; 2006; 77 Suppl 4():3-11. PubMed ID: 17370564
    [No Abstract]   [Full Text] [Related]  

  • 17. High loading dose AmBisome is efficacious and well tolerated in the management of invasive fungal infection in hematology patients.
    McLintock LA; Cook G; Holyoake TL; Jones BL; Kinsey SE; Jackson GH
    Haematologica; 2007 Apr; 92(4):572-3. PubMed ID: 17488675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-dose amphotericin for prevention of serious fungal infection following liver transplantation.
    Shah T; Lai WK; Gow P; Leeming J; Mutimer D
    Transpl Infect Dis; 2005; 7(3-4):126-32. PubMed ID: 16390401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disseminated neonatal Trichosporon beigelii infection: successful treatment with liposomal amphotericin B.
    Sweet D; Reid M
    J Infect; 1998 Jan; 36(1):120-1. PubMed ID: 9515683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experience with liposomal amphotericin B at the Hematology-Oncology Department Children's Hospital Salata Medical School, University of Zagreb.
    Konja J; Glavas B; Anicić M
    Acta Biomed; 2006; 77 Suppl 2():14-6. PubMed ID: 16918061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.